A multi-modality radiomics-based model for predicting recurrence in non-small cell lung cancer

被引:3
|
作者
Christie, Jaryd R. [1 ,2 ]
Abdelrazek, Mohamed [3 ]
Lang, Pencilla [2 ,4 ]
Mattonen, Sarah A. [1 ,2 ,4 ]
机构
[1] Western Univ, Dept Med Biophys, London, ON, Canada
[2] London Reg Canc Program, Baines Imaging Res Lab, London, ON, Canada
[3] Western Univ, Dept Med Imaging, London, ON, Canada
[4] Western Univ, Dept Oncol, London, ON, Canada
来源
MEDICAL IMAGING 2021: BIOMEDICAL APPLICATIONS IN MOLECULAR, STRUCTURAL, AND FUNCTIONAL IMAGING | 2021年 / 11600卷
关键词
Machine learning; radiomics; lung cancer; segmentation; quantitative imaging; outcome prediction; SURVIVAL; FEATURES; CANADA; TUMOR;
D O I
10.1117/12.2586233
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Non-small cell lung cancer (NSCLC) is one of the leading causes of death worldwide. Medical imaging is used to determine cancer staging; however, these images may hold additional information which could be utilized to aid in outcome prediction. A multi-modality radiomics approach incorporating quantitative and qualitative features from the tumor and its surrounding regions, along with clinical features, has yet to be explored. Therefore, we hypothesize that a model containing CT and PET radiomic features, in addition to clinical and qualitative features, has the potential improve risk-stratification of NSCLC patients better than cancer stage alone. Our dataset consisted of 135 NSCLC patients (training: n=94, testing: n=41) who underwent surgical resection. Each region of interest was segmented using a semi-automatic approach on both the pre-treatment CT and PET images. Radiomic features were extracted using the Quantitative Image Feature Engine. A total of 1030 features were extracted including clinical, qualitative, and radiomic features. LASSO regression was used to identify the top features to predict time to recurrence in the training cohort and the model was evaluated in the testing cohort. A total of nine features were selected, including two clinical, one CT, and six PET radiomic features. The model achieved a concordance of 0.81 in the training cohort, which was validated in the testing cohort (concordance=0.79) and outperformed stage alone (concordances=0.68-0.69). This model has the potential to assist physicians in risk-stratifying patients with NSCLC and could be used to identify patients that may benefit from more aggressive or personalized treatment options.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] CT radiomics-based model for predicting TMB and immunotherapy response in non-small cell lung cancer
    Wang, Jiexiao
    Wang, Jialiang
    Huang, Xiang
    Zhou, Yanfei
    Qi, Jian
    Sun, Xiaojun
    Nie, Jinfu
    Hu, Zongtao
    Wang, Shujie
    Hong, Bo
    Wang, Hongzhi
    BMC MEDICAL IMAGING, 2024, 24 (01)
  • [2] CT radiomics-based model for predicting TMB and immunotherapy response in non-small cell lung cancer
    Jiexiao Wang
    Jialiang Wang
    Xiang Huang
    Yanfei Zhou
    Jian Qi
    Xiaojun Sun
    Jinfu Nie
    Zongtao Hu
    Shujie Wang
    Bo Hong
    Hongzhi Wang
    BMC Medical Imaging, 24
  • [3] Radiomics-based Prognosis Analysis for Non-Small Cell Lung Cancer
    Zhang, Yucheng
    Oikonomou, Anastasia
    Wong, Alexander
    Haider, Masoom A.
    Khalvati, Farzad
    SCIENTIFIC REPORTS, 2017, 7
  • [4] Preoperatively predicting survival outcome for clinical stage IA pure-solid non-small cell lung cancer by radiomics-based machine learning
    Yan, Haoji
    Niimi, Takahiro
    Matsunaga, Takeshi
    Fukui, Mariko
    Hattori, Aritoshi
    Takamochi, Kazuya
    Suzuki, Kenji
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2025, 169 (01)
  • [5] Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung Cancer
    Chen, Bihong T.
    Jin, Taihao
    Ye, Ningrong
    Mambetsariev, Isa
    Wang, Tao
    Wong, Chi Wah
    Chen, Zikuan
    Rockne, Russell C.
    Colen, Rivka R.
    Holodny, Andrei I.
    Sampath, Sagus
    Salgia, Ravi
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Multi-level multi-modality (PET and CT) fusion radiomics: prognostic modeling for non-small cell lung carcinoma
    Amini, Mehdi
    Nazari, Mostafa
    Shiri, Isaac
    Hajianfar, Ghasem
    Deevband, Mohammad Reza
    Abdollahi, Hamid
    Arabi, Hossein
    Rahmim, Arman
    Zaidi, Habib
    PHYSICS IN MEDICINE AND BIOLOGY, 2021, 66 (20)
  • [7] Review of the use of radiomics to assess the risk of recurrence in early-stage non-small cell lung cancer
    Libling, William Adam
    Korn, Ronald
    Weiss, Glen J.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (07) : 1575 - 1589
  • [8] Role of surgery in multi-modality treatment for carcinomatous pleuritis in patients with non-small cell lung cancer
    Tetsuhiko Go
    Noriyuki Misaki
    Natsumi Matsuura
    Sung Soo Chang
    Shintarou Tarumi
    Hiroyasu Yokomise
    Surgery Today, 2015, 45 : 197 - 202
  • [9] Role of surgery in multi-modality treatment for carcinomatous pleuritis in patients with non-small cell lung cancer
    Go, Tetsuhiko
    Misaki, Noriyuki
    Matsuura, Natsumi
    Chang, Sung Soo
    Tarumi, Shintarou
    Yokomise, Hiroyasu
    SURGERY TODAY, 2015, 45 (02) : 197 - 202
  • [10] Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non-small cell lung cancer
    Liu, Chaoyuan
    Zhao, Wei
    Xie, Junpeng
    Lin, Huashan
    Hu, Xingsheng
    Li, Chang
    Shang, Youlan
    Wang, Yapeng
    Jiang, Yingjia
    Ding, Mengge
    Peng, Muyun
    Xu, Tian
    Hu, Ao'ran
    Huang, Yuda
    Gao, Yuan
    Liu, Xianling
    Liu, Jun
    Ma, Fang
    FRONTIERS IN IMMUNOLOGY, 2023, 14